News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

This article was first published 14 years ago
Rediff.com  » News » Cheap HIV test developed, result in 30 mins!

Cheap HIV test developed, result in 30 mins!

Source: PTI
June 01, 2009 12:07 IST
Get Rediff News in your Inbox:

Scientists have developed an HIV test which they claim works in just 30 minutes and can be performed anywhere in the world -- no laboratory required.

An international team has developed the prototype CD4 rapid test, similar in design to a home pregnancy test, which works with a finger-prick blood sample to measure the numbers of CD4+ T-cells in a person's blood. CD4+ T-cells are critical for a healthy functioning immune system and are slowly destroyed during the course of an HIV infection, thereby making patients increasingly vulnerable to illness.

According to lead scientist Professor Suzanne Crowe of Burnet Institute, the test enables patients at the point of care to find out within just 30 minutes if they should begin antiretroviral treatment without any laboratory equipment being required.

The majority of patients in developing countries start antiretroviral therapy based on symptoms alone.

Research shows that if HIV patients wait till they're sick to start treatment they have a much poorer outcome than if treatment were started based on a CD4 count.

The majority of patients in the developing world don't currently have access to CD4 testing as it is expensive, and relies on sophisticated laboratory testing requiring specially trained operators.

Where testing facilities exist, it is often too difficult for people in rural areas to access them and it can take weeks to obtain results. Currently 33 million people globally have been diagnosed with HIV, many of them in resource poor countries.

And, having completed the first phase of trials, the prototype test developed by the scientists, in collaboration with colleagues at Rush University Medical Centre, Chicago and Duke University, North Carolina, will undergo further trials to ensure the assay offers reliable and reproducible results.

Get Rediff News in your Inbox:
Source: PTI© Copyright 2024 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.
 
CHINESE CHALLENGE - 2022

CHINESE CHALLENGE